作者: Stéphanie Dulucq , Caroline Laverdière , Daniel Sinnett , Maja Krajinovic
DOI: 10.1517/17425255.2014.893294
关键词: Precision medicine 、 Drug 、 Pharmacogenetics 、 Oncology 、 Pharmacogenomics 、 Childhood Acute Lymphoblastic Leukemia 、 Internal medicine 、 Drug resistance 、 Medicine 、 Immunology 、 Candidate gene 、 Chemotherapy
摘要: … Subsequent analysis of the ADRB2 promoter polymorphism (… from the toxic effects of anthracycline. The TT genotype of C … genome of the tumor can alter the toxicity or efficacy of …